Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-06-30
2010-10-05
Andres, Janet L (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S314000, C514S376000, C514S340000, C546S271400, C546S166000, C548S227000
Reexamination Certificate
active
07807692
ABSTRACT:
Phenoxyphenyl and phenoxybenzyl oxazolidine-2,4-diones and thiazolidine-2,4-diones are agonists or partial agonists of PPAR gamma and are useful in the treatment and control of hyperglycemia that is symptomatic of type II diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.
REFERENCES:
patent: 6784184 (2004-08-01), Epstein et al.
patent: 2007/0173434 (2007-07-01), Shi et al.
patent: 1 709 014 (2006-10-01), None
patent: 99/32465 (1999-07-01), None
patent: WO 01/30343 (2001-05-01), None
patent: WO 02/08188 (2002-01-01), None
patent: WO 2005/007095 (2005-01-01), None
Hcaplus Abstract 138:221580, “Preparation of arylsulfonylthiazolidinediones as inhibitors of farnesyl-protein transferase”, Salaski et. al., 2003.
H. K. Rami et al., “Synthetic ligands for PPAR gamma—review of patent literature 1994-1999”, Expert Opinion on Therapeutic Patents, vol. 10, No. 5, pp. 623-634 (2000).
Dropinski James F.
Meinke Peter T.
Shi Guo Q.
Zhang Yong
Andres Janet L
Fair Janet E.
Merck Sharp & Dohme Corp.
Robinson Binta M
Todaro John C.
LandOfFree
Antidiabetic oxazolidinediones and thiazolidinediones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antidiabetic oxazolidinediones and thiazolidinediones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antidiabetic oxazolidinediones and thiazolidinediones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4161685